ORC - NYSE

Orchid Island Capital, Inc.

ORC·NYSE

$6.60

-2.1%

Real EstateREIT - Mortgage

Orchid Island Capital, Inc., a specialty finance company, invests in residential mortgage-backed securities (RMBS) in the United States. The company's RMBS is backed by single-family residential mortgage loans, referred as Agency RMBS. Its portfolio includes traditional pass-through Agency RMBS, such as mortgage pass through certificates and collateralized mortgage obligations; and structured Agency RMBS comprising interest only securities, inverse interest only securities, and principal only securities. The company qualifies as a real estate investment trust for federal income tax purposes. Orchid Island Capital, Inc. was incorporated in 2010 and is based in Vero Beach, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.00B

EPS1.2400

P/E Ratio5.32

Earnings Date07/23/2026

11.68B

Assets

104%

3Y+202.0%

5Y+188.0%

10Y+272.0%

10.30B

Total Liabilities

104%

3Y+201.0%

5Y+183.0%

10Y+267.0%

1.37B

Total Equity

105%

3Y+213.0%

5Y+230.0%

10Y+312.0%

Orchid Island Capital, Inc. Funding & Solvency Profile

ORC · NYSE

Current Assets

Cash & Cash Equivalents724.56M

Net Receivables49.13M

Inventory0.00

Other Current Assets137.87M

Total Current Assets912 M

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments10.90B

Other Non-Current Assets-137.22M

Total Non-Current Assets11 B

Total Assets

11.68B

Financial Health Analysis

Current Ratio

0.09x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Debt-to-Equity Ratio

7.51x

High financial leverage. Heavy reliance on debt may indicate increased financial risk and potential solvency concerns.

Working Capital

-9332636000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

8% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Financial stress indicators: Both liquidity and leverage metrics raise concerns. The company may face challenges meeting obligations and should focus on strengthening its balance sheet.

Orchid Island Capital, Inc. Balance Sheet

ORC • NYSE

Orchid Island Capital, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	724.6M	309.3M	171.9M	205.7M	385.1M	299.5M	193.8M	108.3M	214.4M	73.5M	57.2M	93.1M	8.2M	2.5M	1.9M	1.2M
Short-Term Investments	0.0	0.0	69.1M	0.0	0.0	0.0	3.6B	0.0	17.2M	0.0	669K	1.2M	-17.9M	0.0	90.8K	0.0
Cash & Short-Term Investments	724.6M	309.3M	241M	205.7M	385.1M	299.5M	278.7M	108.3M	231.5M	73.5M	57.9M	94.4M	-9.7M	2.5M	2M	1.2M
Net Receivables	49.1M	23M	15M	11.5M	18.9M	10.1M	12.4M	235M	14.4M	11.5M	8.5M	6.2M	1.6M	486K	374.6K	93.3K
Accounts Receivables	49.1M	23M	15M	11.5M	18.9M	0.0	12.4M	0.0	14.4M	11.5M	8.5M	6.2M	1.6M	440.9K	374.6K	93.3K
Other Receivables	0.0	0.0	0.0	0.0	0.0	10.1M	0.0	235M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-495.1K	0.0	0.0
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1K	10K	0.0
Other Current Assets	137.9M	-332.4M	-256M	-217.2M	-404M	-309.6M	0.0	0.0	46.8M	32.5M	0.0	0.0	0.0	944.1K	0.0	0.0
Total Current Assets	911.6M	0.0	0.0	0.0	0.0	0.0	291.1M	343.3M	292.8M	117.4M	66.4M	100.6M	9.7M	3.5M	2.3M	1.3M
NON-CURRENT ASSETS
Long-Term Investments	10.9B	44.2M	77.6M	27.4M	41.9M	0.0	6.6M	22.9M	32.3M	49.9M	62.4M	31.9M	15.4M	5.8M	56M	25.8M
Other Non-Current Assets	-137.2M	-44.2M	-77.6M	-27.4M	-41.9M	0.0	0.0	0.0	-32.3M	-49.9M	-62.4M	-31.9M	0.0	0.0	0.0	0.0
Total Non-Current Assets	10.8B	0.0	0.0	0.0	0.0	0.0	6.6M	22.9M	32.3M	49.9M	62.4M	31.9M	15.4M	5.8M	56M	25.8M
Other Assets	0.0	5.7B	4.3B	3.9B	7.1B	4.1B	3.6B	3B	3.7B	3B	2.1B	1.5B	338.4M	109.6M	100.7K	0.0
Total Assets	11.7B	5.7B	4.3B	3.9B	7.1B	4.1B	3.9B	3.4B	4B	3.1B	2.2B	1.7B	363.6M	118.9M	58.4M	27.1M
LIABILITIES
CURRENT LIABILITIES
Total Payables	56.4M	21.9M	75.6M	16.2M	13.4M	0.0	16.8M	11M	14.7M	7M	1.3M	958K	173K	194.8K	264.1K	24.5K
Accounts Payable	31.4M	10.8M	7.9M	9.2M	788K	0.0	11.1M	6.4M	6.5M	1.8M	863K	628K	91K	194.8K	26.1K	4.4K
Other Payables	25M	11.1M	67.7M	7M	12.6M	0.0	5.7M	4.6M	8.2M	5.2M	465K	330K	82K	0.0	238.1K	20.1K
Accrued Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1M	7.3M	2.4M	0.0	958K	0.0	0.0	0.0	0.0
Short Term Debt	10.2B	0.0	0.0	0.0	0.0	3.6B	0.0	0.0	0.0	0.0	2B	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	-56.4M	-21.9M	-75.6M	-16.2M	-13.4M	-3.6B	0.0	-18.1M	-22.1M	2.8B	-2B	-1.9M	0.0	-194.8K	-264.1K	-24.5K
Total Current Liabilities	10.2B	0.0	0.0	0.0	0.0	0.0	16.8M	18.1M	22.1M	2.8B	2B	2.7M	173K	194.8K	0.0	0.0
NON-CURRENT LIABILITIES
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	3.5B	3.1B	3.6B	2.8B	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Liabilities	59.9M	0.0	0.0	0.0	0.0	0.0	-3.5B	-3.1B	-3.6B	-2.8B	0.0	0.0	0.0	0.0	0.0	0.0
Total Non-Current Liabilities	59.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Liabilities	3.4M	5.1B	3.8B	3.4B	6.3B	3.6B	3.5B	3.1B	3.6B	0.0	2B	1.4B	318.8M	104.1M	44.6M	22.8M
Total Liabilities	10.3B	5.1B	3.8B	3.4B	6.3B	3.6B	3.5B	3.1B	3.6B	2.8B	2B	1.4B	318.8M	104.1M	44.6M	22.8M
SHAREHOLDERS' EQUITY
Common Stock	1.8M	826K	516K	368K	354K	761K	631K	491K	531K	330K	217K	167K	0.0	1.5K	1.5K	441.0
Additional Paid-In Capital	1.6B	1B	849.8M	779.6M	850.5M	432.5M	415M	380M	461.7M	332.4M	253M	217.4M	46.1M	15.4M	15M	4.4M
Retained Earnings	-183.7M	-342.8M	-380.4M	-341.2M	-82.8M	-18M	-20.1M	-44.4M	0.0	0.0	0.0	492K	-1.4B	-686K	-1.2M	-30.2K
Accumulated Other Comprehensive Income/Loss	418K	139K	17K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4B	0.0	0.0	0.0
Total Stockholders' Equity	1.4B	668.5M	469.9M	438.8M	768.1M	415.3M	395.5M	336.1M	462.2M	332.8M	253.3M	218.1M	44.8M	14.7M	13.8M	4.4M
Total Equity	1.4B	668.5M	469.9M	438.8M	768.1M	415.3M	395.5M	336.1M	462.2M	332.8M	253.3M	218.1M	44.8M	14.7M	13.8M	4.4M
SUMMARY
Total Liabilities & Equity	11.7B	5.7B	4.3B	3.9B	7.1B	4.1B	3.9B	3.4B	4B	3.1B	2.2B	1.7B	363.6M	118.9M	58.4M	27.1M
Total Investments	10.9B	44.2M	146.7M	27.4M	41.9M	0.0	3.6B	22.9M	-32.3M	49.9M	63.1M	-7.8M	-2.4M	5.8M	56M	25.8M
Total Debt	10.2B	0.0	0.0	0.0	0.0	3.6B	3.4B	3M	216K	218K	187.5M	1.4B	318.6M	0.0	0.0	0.0
Net Debt	9.5B	-309.3M	-171.9M	-205.7M	-385.1M	3.3B	-193.8M	-108.3M	-214.4M	-73.5M	130.3M	-93.1M	-8.2M	-2.5M	-1.9M	-1.2M
Shares Outstanding	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160	151,712,160

SEC Filings

ORC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 13, 2026	May 13, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 27, 2026	June 09, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 24, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 23, 2026	April 23, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 16, 2026	April 15, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 18, 2026	March 18, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 20, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 14, 2026	January 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 07, 2026	January 07, 2026	2026	View Filing

Showing 1 to 10 of 327 filings

Related Guides

Blog Categories

Continue your ORC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.